ALECTOR INC. - COMMON STOCK

Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease

07 сен 2023 04:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

31 авг 2023 04:00:00 Источник Nasdaq GlobeNewswire

Alector Reports Second Quarter 2023 Financial Results and Provides Business Update

03 авг 2023 13:05:01 Источник Nasdaq GlobeNewswire

Alector to Host Mid-Year Earnings Conference Call

27 июл 2023 05:30:00 Источник Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

06 июн 2023 04:00:00 Источник Nasdaq GlobeNewswire

Alector Reports First Quarter 2023 Financial Results and Provides Business Update

04 май 2023 13:05:00 Источник Nasdaq GlobeNewswire

Alector to Participate in the BofA Securities 2023 Healthcare Conference

02 май 2023 04:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

01 мар 2023 13:05:00 Источник Nasdaq GlobeNewswire

Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

28 фев 2023 13:05:01 Источник Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

08 дек 2022 13:30:00 Источник Nasdaq GlobeNewswire

Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases

29 ноя 2022 08:05:00 Источник Nasdaq GlobeNewswire

Alector Reports Third Quarter 2022 Financial Results and Provides Business Update

08 ноя 2022 13:05:01 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

07 ноя 2022 04:00:01 Источник Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 ноя 2022 13:30:00 Источник Nasdaq GlobeNewswire

Alector Announces Promotion of Clare Hunt to Chief People Officer

13 окт 2022 05:00:01 Источник Nasdaq GlobeNewswire

Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 окт 2022 13:30:00 Источник Nasdaq GlobeNewswire

Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)

12 сен 2022 04:00:00 Источник Nasdaq GlobeNewswire

Alector to Participate in Upcoming Healthcare Conferences

07 сен 2022 04:00:01 Источник Nasdaq GlobeNewswire

Alector Reports Second Quarter 2022 Financial Results and Provides Business Update

04 авг 2022 13:05:01 Источник Nasdaq GlobeNewswire

Alector to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

08 июн 2022 04:00:00 Источник Nasdaq GlobeNewswire